Modifying an immunogenic epitope on a therapeutic protein: a step towards an improved system for antibody-directed enzyme prodrug therapy (ADEPT)

Authors

¹ Cancer Research UK Targeting and Imaging Group, Department of Oncology, Royal Free and University College Medical School, University College London, Rowland Hill Street, London NW3 2PF, UK
² Institute of Infections, Immunity and Inflammation, University of Nottingham, Floor C, West Block, Queens Medical Centre, Nottingham NG7 2UH, UK
³ Health Protection Agency, Porton Down, Salisbury, Wiltshire SP4 0JG, UK
⁴ Department of Immunology, Royal Free and University College Medical School, University College London, Rowland Hill Street, London NW3 2PF, UK

Type